[go: up one dir, main page]

DK151585D0 - DNA sequence - Google Patents

DNA sequence

Info

Publication number
DK151585D0
DK151585D0 DK151585A DK151585A DK151585D0 DK 151585 D0 DK151585 D0 DK 151585D0 DK 151585 A DK151585 A DK 151585A DK 151585 A DK151585 A DK 151585A DK 151585 D0 DK151585 D0 DK 151585D0
Authority
DK
Denmark
Prior art keywords
dna
dna sequence
dna fragment
desired polypeptide
coding
Prior art date
Application number
DK151585A
Other languages
Danish (da)
Inventor
Henrik Dalboege Andersen
Hans Henrik Marstrand Dahl
Original Assignee
Nordisk Gentofte
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nordisk Gentofte filed Critical Nordisk Gentofte
Priority to DK151585A priority Critical patent/DK151585D0/en
Publication of DK151585D0 publication Critical patent/DK151585D0/en
Priority to AU56950/86A priority patent/AU5695086A/en
Priority to JP61502217A priority patent/JP2612264B2/en
Priority to AT86902345T priority patent/ATE92961T1/en
Priority to EP86902345A priority patent/EP0218651B1/en
Priority to DE86902345T priority patent/DE3688870T2/en
Priority to PCT/DK1986/000029 priority patent/WO1986005804A1/en
Priority to DK580886A priority patent/DK580886A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/66—General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Endocrinology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Diabetes (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

A DNA sequence consisting of a first DNA fragment containing the coding sequence for a desired polypeptide having N-amino acids, followed by the translation stop signal and if desired some untranslated bases which may comprise a restriction site, is coupled together with a second DNA fragment having the DNA structure necessary for replication of the cloning medium, at the last base after the N codon. This intermediate is useful for introduction into plasmids coding for a desired polypeptide.
DK151585A 1985-04-03 1985-04-03 DNA sequence DK151585D0 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
DK151585A DK151585D0 (en) 1985-04-03 1985-04-03 DNA sequence
AU56950/86A AU5695086A (en) 1985-04-03 1986-04-03 A dna sequence
JP61502217A JP2612264B2 (en) 1985-04-03 1986-04-03 DNA sequence
AT86902345T ATE92961T1 (en) 1985-04-03 1986-04-03 DNA SEQUENCE.
EP86902345A EP0218651B1 (en) 1985-04-03 1986-04-03 A dna sequence
DE86902345T DE3688870T2 (en) 1985-04-03 1986-04-03 DNS SEQUENCE.
PCT/DK1986/000029 WO1986005804A1 (en) 1985-04-03 1986-04-03 A dna sequence
DK580886A DK580886A (en) 1985-04-03 1986-12-03 DNA sequence

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK151585A DK151585D0 (en) 1985-04-03 1985-04-03 DNA sequence

Publications (1)

Publication Number Publication Date
DK151585D0 true DK151585D0 (en) 1985-04-03

Family

ID=8105641

Family Applications (2)

Application Number Title Priority Date Filing Date
DK151585A DK151585D0 (en) 1985-04-03 1985-04-03 DNA sequence
DK580886A DK580886A (en) 1985-04-03 1986-12-03 DNA sequence

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK580886A DK580886A (en) 1985-04-03 1986-12-03 DNA sequence

Country Status (7)

Country Link
EP (1) EP0218651B1 (en)
JP (1) JP2612264B2 (en)
AT (1) ATE92961T1 (en)
AU (1) AU5695086A (en)
DE (1) DE3688870T2 (en)
DK (2) DK151585D0 (en)
WO (1) WO1986005804A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5340725A (en) * 1986-10-09 1994-08-23 Fujisawa Pharmaceutical Co., Ltd. Expression vector for insulin-like growth factor I and method of production
EP0264074B1 (en) * 1986-10-09 1992-12-30 Fujisawa Pharmaceutical Co., Ltd. Expression vector for insulin-like growth factor i
JPH04503154A (en) * 1988-11-07 1992-06-11 ルニベルシー・ド・ルタ・ア・リージュ modified human growth hormone
CN1269805A (en) * 1997-07-14 2000-10-11 博尔德生物技术公司 Derivatives of growth hormone and related proteins
US6753165B1 (en) 1999-01-14 2004-06-22 Bolder Biotechnology, Inc. Methods for making proteins containing free cysteine residues
US20080076706A1 (en) 1997-07-14 2008-03-27 Bolder Biotechnology, Inc. Derivatives of Growth Hormone and Related Proteins, and Methods of Use Thereof
US8288126B2 (en) 1999-01-14 2012-10-16 Bolder Biotechnology, Inc. Methods for making proteins containing free cysteine residues
CA2447632C (en) 2000-06-16 2011-08-02 Asterion Limited Fusion protein agonist comprising a growth hormone binding portion and an external domain of a growth hormone receptor

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2963374D1 (en) * 1978-10-10 1982-09-09 Univ Leland Stanford Junior Recombinant dna, method for preparing it and production of foreign proteins by unicellular hosts containing it
US4342832A (en) * 1979-07-05 1982-08-03 Genentech, Inc. Method of constructing a replicable cloning vehicle having quasi-synthetic genes
CA1200773A (en) * 1980-02-29 1986-02-18 William J. Rutter Expression linkers
JPS5967297A (en) * 1982-10-08 1984-04-16 Kyowa Hakko Kogyo Co Ltd Novel vector
DE3247922A1 (en) * 1982-12-24 1984-06-28 Boehringer Ingelheim International GmbH, 6507 Ingelheim DNA SEQUENCES, THEIR PRODUCTION, PLASMIDES CONTAINING THESE SEQUENCES AND THE USE THEREOF FOR THE SYNTHESIS OF EUKARYOTIC GENE PRODUCTS IN PROKARYOTS
US4755465A (en) * 1983-04-25 1988-07-05 Genentech, Inc. Secretion of correctly processed human growth hormone in E. coli and Pseudomonas
JPS60502136A (en) * 1983-08-10 1985-12-12 アムジエン　インコーポレイテツド Expression of interlukin 2 by microorganisms

Also Published As

Publication number Publication date
AU5695086A (en) 1986-10-23
DK580886D0 (en) 1986-12-03
WO1986005804A1 (en) 1986-10-09
DE3688870T2 (en) 1993-12-23
DE3688870D1 (en) 1993-09-16
JPS62502657A (en) 1987-10-15
ATE92961T1 (en) 1993-08-15
EP0218651A1 (en) 1987-04-22
EP0218651B1 (en) 1993-08-11
JP2612264B2 (en) 1997-05-21
DK580886A (en) 1986-12-03

Similar Documents

Publication Publication Date Title
DE3382760D1 (en) Production of functional human urokinase polypeptides.
DK120387D0 (en) HYBRID INTERFERONES, THEIR USE AS MEDICINE AND INTERMEDIATES FOR THE MANUFACTURE OF ANTIBODIES AND THEIR USE, AND PROCEDURE FOR THEIR PREPARATION
DK576782A (en) BICYCLIC AMINO ACIDS, PROCEDURES AND INTERMEDIATES FOR THEIR PREPARATION AND THEIR USE
DK320287A (en) PROCEDURE FOR USING BARL FOR Separation of Alien Proteins
DK221589A (en) PROCEDURE FOR EXPRESSING NON-YELLOW PROTEIN IN A GERVAIR AND TRANSFORMED GERVAIR
FI862756A (en) FIBROEKTINER.
DK130683D0 (en) DERIVATIVES OF BICYCLIC AMINO ACIDS, PROCEDURES FOR THE PRODUCTION THEREOF, MENTALS CONTAINING THESE COMPOUNDS AND THEIR USE AND BICYCLIC AMINO ACIDS AS INTERMEDIATES AND PROCEDURES THEREOF
NO834128L (en) NEW DERIVATIVES OF TRICYCLIC AMINO ACIDS, PROCEDURES FOR THEIR PREPARATION, MATERIALS CONTAINING THESE, AND THEIR USE, AND NEW BICYCLIC AMINO ACIDS AS INTERMEDIATES AND PROCEDURES
DK430486A (en) PROCEDURE FOR THE EXTRACTION OF PROTEIN
DK151585D0 (en) DNA sequence
ES547436A0 (en) A PROCEDURE FOR PRODUCING CLONED COMPLEMENTARY DNA OR ITS MODIFIED DNA CODING A TUMOR DENECROSIS FACTOR POLYPEPTIDE
NO174161C (en) Process for the preparation of human interferon polypeptide derivatives, and recombinant plasmids containing a DNA fragment encoding the polypeptides
DE3481386D1 (en) DETERMINATION OF FIBRINE WITH FIBRINE-SPECIFIC ANTIBODY.
NO861772L (en) PROCEDURE FOR THE PREPARATION OF PROTEIN HYDROLYZATE.
DE58908428D1 (en) Secretary mutant of Escherichia coli.
DK38889A (en) ONCOGEN-ENCODED POLYPEPTIDE WITH GROWTH FACTOR ACTIVITY
DK203087A (en) PROCEDURE FOR THE MANUFACTURE OF FUSION PROTEINS AND THE USE OF THE FUSION PROTEIN MANUFACTURED AS A VACCINE
DK447083A (en) DNA CODING HUMANT INTERFERON GAMMA, RECOMBINANT DNA CONTAINING THIS DNA, MICROORGANISM CONTAINING THE RECOMBINANT DNA AND PROCEDURE FOR MANUFACTURING HUMANT INTERFERON GAMMA POLYPEPTIDE
ES547600A0 (en) PROCEDURE FOR PREPARING ENCARYOTIC, PROCARIOTIC OR VIRAL PROTEINS.
FI882238A (en) FOERBAETTRINGAR I SAMBAND MED ORGANISKA FOERENINGAR
DE3682105D1 (en) SAMPLE, TRACERS, IMMUNOGENIC AND ANTIBODIES OF ETHOSUXIMID.
DK241688D0 (en) PROCEDURE FOR THE MANUFACTURE OF FUSION PROTEINS
DE3683178D1 (en) METHOD FOR PRODUCING MONOCLONAL ANTIBODIES AGAINST PLASMINOGEN ACTIVATOR FACTOR.
DK130290D0 (en) Lymphomas, DNA sequences encoding these lymphomas and pharmaceuticals containing these lymphomas
DK661489A (en) EXPRESSION PLASMIDS FOR EXPRESSION OF PROTEINS IN E. COLI AND THEIR USE

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment
PBP Patent lapsed